NCT06184997

Brief Summary

Randomized clinical trial in which 160 participants (80 men, 80 women) will be assigned to one of two groups (40 participants per group), to determine the effects of isotonic drink on different health parameters, following published recommendations. Subjects will be electronically randomized by block design into two arms: an experimental group: isotonic drink and a control group (placebo): normal water.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for not_applicable healthy-volunteers

Timeline
Completed

Started Jan 2024

Typical duration for not_applicable healthy-volunteers

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 14, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 29, 2023

Completed
10 days until next milestone

Study Start

First participant enrolled

January 8, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

March 25, 2025

Status Verified

March 1, 2025

Enrollment Period

6 months

First QC Date

December 14, 2023

Last Update Submit

March 24, 2025

Conditions

Outcome Measures

Primary Outcomes (18)

  • Body composition

    Measurement of body composition using bioimpedance with the Biodyxpert device.

    12 weeks

  • Body composition

    Measurement of body composition through anthropometry.

    12 weeks

  • Blood pressure

    Measurement of systolic and diastolic blood pressure. Using an OMROM upper arm blood pressure monitor.

    12 weeks

  • Perception of quality of life

    Using a Quality of Life Questionnaire (SF36). Quality of Life Questionnaire is a comprehensive questionnaire that covers various attributes of an individuals life. It covers a variety of demographic questions to get better quality data and information before analyzing the quality of life of an individual.The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.

    12 weeks

  • Perceived stress

    Measurement of perceived stress using the Perceived Stress Scale (PSS)

    12 weeks

  • BLOOD GLUCOSE

    Glucose levels in blood by blood analysis.

    12 weeks

  • BLOOD INSULIN

    Insulin levels in blood by blood analysis.

    12 weeks

  • BLOOD LIPID PORFILE

    Cholesterol and triglycerides levels in blood.

    12 weeks

  • Specific color of urine

    12 weeks

  • Specific gravity of urine

    12 weeks

  • Minerals in urine

    K+ (Potassium), Na+ (Sodium), Mg2+ (Magnesium), Ca2+ (Calcium)

    12 weeks

  • Urinary pH

    12 weeks

  • Mood States Profile

    The POMS (Profile of Mood States) questionnaire is a psychological assessment tool widely used to measure mood states. It consists of a series of words or phrases that describe feelings and emotions. Participants are asked to rate each item on a scale, indicating how well it represents their mood over a specific period. The POMS measures six different mood dimensions: Tension-Anxiety, Depression-Dejection, Anger-Hostility, Vigor-Activity, Fatigue-Inertia, and Confusion-Bewilderment. It's commonly used in clinical settings, as well as in research studies, to assess the impact of various treatments or interventions on mood states. The POMS is valued for its sensitivity in detecting mood changes over time and its ability to differentiate between various mood states.

    12 weeks

  • Evaluation of constipation symptoms by the patient

    The PAC-SYM (Patient Assessment of Constipation Symptoms) is a self-report questionnaire designed to evaluate the symptoms of constipation from the patient's perspective. It is commonly used in clinical research and practice to assess the severity and impact of constipation symptoms. The questionnaire includes a series of items that ask patients to rate the frequency and severity of their constipation-related symptoms, such as abdominal discomfort, straining, and incomplete bowel movements.

    12 weeks

  • Evaluation of the quality of life of patients with constipation (PAC-QOL)

    The PAC-QOL (Patient Assessment of Constipation Quality of Life) questionnaire is a specialized tool designed to assess the quality of life in individuals suffering from constipation. It is a patient-reported outcome measure that focuses on how constipation affects a person's daily life, well-being, and overall health.

    12 weeks

  • Sleep quality

    Measurement of sleep quality using the Pittsburgh sleep quality index.

    12 weeks

  • Liver biomarkers

    Measurement of liver biomarkers through a blood test; Aspartate aminotransferase (AST or GOT), Alanine aminotransferase (ALT or GPT) and Bilirubin

    12 weeks

  • Microbiome Indices

    Microbiome indices through stool sample; Firmicutes/Bacteroidetes, Bacteroides/Prevotella, Enterobacteria/Enterococcus, Clostridium coccoides/perfringens

    12 weeks

Secondary Outcomes (1)

  • Weight

    12 weeks

Study Arms (2)

CONTROL GROUP

PLACEBO COMPARATOR

Volunteer participants who will drink water

Other: PLACEBO

ISOTONIC DRINK GROUP

EXPERIMENTAL

Volunteer participants who will drink Natural isotonic drink based on 20% Atlantic sea water, mixed with lemon and stevia.

Other: INTAKE OF ISOTONIC DRINK

Interventions

Intake of natural isotonic drink based on 20% Atlantic sea water, mixed with lemon and stevia.

ISOTONIC DRINK GROUP
PLACEBOOTHER

Intake of natural mineral water

CONTROL GROUP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • men and women aged \>18 years;
  • body mass index (BMI) of 18 to 25 kg/m\^2;

You may not qualify if:

  • individuals who have taken medication up to 3 months before the start of the study or supplements during the study;
  • individuals with a history of gastrointestinal pathology or disorder such as duodenal ulcer, chronic colitis, or chronic inflammatory disease/surgery of the gastrointestinal tract (Crohn\'s disease, ulcerative colitis), celiac disease, or irritable bowel syndrome;
  • individuals with serious acute or chronic diseases, treatments, or recent surgery;
  • individuals with a report of serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), or gamma-glutamyl transferase (GGT) above the upper limit of the reference interval.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alejandro Martínez Rodríguez

Elche, Alicante, 03203, Spain

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants will not be aware that there are other people consuming a different type of drink than theirs. The person analyzing the results will also be unaware. However, the researchers will be aware because they need to control the supply.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Participants will be assigned to group A (water, placebo) or group B (sugar-free isotonic drink), and will be instructed to consume 265 ml of water or 265 ml of sugar-free isotonic drink, respectively, every day for 12 weeks. During the study period, participants will be advised to maintain their usual diet and physical activity.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full professor

Study Record Dates

First Submitted

December 14, 2023

First Posted

December 29, 2023

Study Start

January 8, 2024

Primary Completion

July 1, 2024

Study Completion

December 31, 2024

Last Updated

March 25, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations